ImmunOs Therapeutics AG
Drug development to antagonise various kind of tumours
ImmunOs Therapeutics AG is leading the next generation of immunotherapies by fast-tracking new discoveries to enhance combination therapies with novel human immunomodulatory proteins that have a role in both the innate and adaptive immune system for cancer treatment.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
19.09.2024
ImmunOs Therapeutics secures USD 11M to advance cancer therapy (venturelab.swiss)
18.09.2024
Immunos Therapeutics raises USD11 million (startupticker.ch)
15.08.2024
Clinical advancements at ImmunOs Therapeutics and Noema Pharma (startupticker.ch)
20.10.2023
Early-stage pharmaceutical companies make strides in cancer- and immunotherapy (startupticker.ch)
No milestones
No Jobs
No videos and documents
TOP 100 Scale-ups
Being among the TOP 100 Startups in Switzerland has become a seal of approval for founders, and the TOP 100 Swiss Startup Ranking provides them with the recognition they deserve. As startups cannot appear in the startup ranking for more than five years after incorporation, the TOP 100 Swiss Scale-up Ranking has been introduced. A growth jury is asked to select the TOP 100 Swiss Scale-ups. These companies, aged five up to 10 years, show the greatest potential for further growth and represent the future Swiss unicorns
ImmunOs Therapeutics AG
Drug development to antagonise various kind of tumours
Website:
www.immunostherapeutics.com/
Headquarter:
Schlieren
Foundation Date:
December 2014
Technology:
- Biotech
Sectors:
- Biotech
- Cancer
- Drug discovery
- Protein drugs